Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Athira Pharma, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 150K | Jan 19, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATHA | Athira Pharma, Inc. | Jan 19, 2023 | 1 | $0 | 4 | Jan 23, 2023 | Chief Financial Officer |
ATHA | Athira Pharma, Inc. | Dec 28, 2022 | 2 | $144K | 4 | Dec 30, 2022 | Chief Financial Officer |
ATHA | Athira Pharma, Inc. | Jun 22, 2022 | 3 | $5.12K | 4 | Jun 24, 2022 | Chief Financial Officer |
ATHA | Athira Pharma, Inc. | Apr 12, 2022 | 2 | $31.9K | 4 | Apr 12, 2022 | Chief Financial Officer |
ATHA | Athira Pharma, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Chief Financial Officer |
ATHA | Athira Pharma, Inc. | Jan 4, 2022 | 3 | $20.2K | 4 | Jan 6, 2022 | Chief Financial Officer |
ATHA | Athira Pharma, Inc. | May 18, 2021 | 3 | $31K | 4 | Jun 10, 2021 | Chief Financial Officer |